Diabetic Retinopathy
An Introduction to Diabetic Retinopathy
Advances in pharmacotherapy following the introduction of anti-VEGF agents and intravitreal steroids have transformed the diabetic retinopathy treatment landscape; and new imaging techniques, such as optical coherence tomography-angiography (OCT-A), have helped to guide treatment.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
This week in ophthalmology: a new ranibizumab biosimilar approval, smartphone-based artificial intelligence (AI) for ocular surface malignancy detection, an update on corneal allogenic intrastromal ring segments in keratoconus, diabetic eye disease data from ADA 2026 and FDA designations for a potential neurotrophic keratitis therapy. Here are five stories to catch up on this week.
New data presented at ADA 2026 explored diabetic retinopathy risk, incretin therapy safety, AI-based screening, real-world DME outcomes and a potential new oral approach to retinal vascular disease.
At the ARVO 2026 Annual Meeting, DME remained a major focus, with multiple studies exploring how clinicians may extend treatment intervals, improve outcomes in suboptimal responders and target inflammatory pathways beyond VEGF. Across phase 2 and phase 3 trials, as well as real-world observational studies, key themes included long-term durability with faricimab, sustained-delivery approaches, and growing evidence supporting dual-pathway strategies that may help address the heterogeneity of DME in routine practice.
In this expert Q&A, Dr Marina Roizenblatt shares a global and developing-world perspective on rapidly progressing DR, drawing on her clinical experience in Brazil to explore how biological risk factors, health system limitations and pragmatic treatment approaches intersect in real-world practice.
The first months of 2026 have already seen a number of interesting studies and reviews published across the ophthalmology literature, setting the stage for another year of progress in the field. Below, we highlight a selection of recent papers from major journals that we found particularly notable over the past few weeks.
As 2026 gets underway, January has delivered a busy start across regulation, clinical research and community awareness. Here are some of the top news and research stories from the month.
2025 has brought a wave of innovation and developments that are already reshaping day-to-day clinical practice. We asked our key faculty to reflect on what they believe has been most impactful so far this year – here’s what they told us.
Specializing in ophthalmology is an exciting milestone – but it can also feel overwhelming. The transition from training to independent practice comes with big decisions, new responsibilities and the pressure to build a career that will stand the test of time. We asked members of our faculty and Future Leaders what guidance they would offer to colleagues just beginning their careers.
In this Voices in vision Q&A, Dr Arrigo discusses the current clinical challenges facing retinal specialists, the developments that have shaped practice over the past year, and how artificial intelligence could transform diagnosis and patient management in the years ahead.
In this Q&A, Dr Cicinelli reflects on the growing challenge of managing eye care in an aging population and the opportunities this brings for innovation.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
Encouraging results have emerged from two phase II clinical trials investigating a novel treatment, PER-001, for glaucoma and diabetic retinopathy, two of the most common causes of blindness globally. Delivered via a sustained-release intravitreal implant every six months, PER-001 improved both vision and retinal structure compared with control groups.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
Susvimo® (ranibizumab injection) has become the first FDA-approved continuous delivery system for diabetic retinopathy (DR), reducing treatment frequency to once every nine months.1 The approval is based on the positive results of the phase III Pavilion study, showing significant improvement in disease severity.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
